One study found adults diagnosed with gender incongruence were nearly four times more likely to receive antidepressants or anti-anxiety medications than the general population.

An analysis¹ of the 2005−2015 Swedish Total Population and Prescribed Drug Registers examined 2,679 adults diagnosed with gender incongruence. Compared to the general population, these individuals were 3.95 times more likely to receive antidepressant prescriptions and 3.43 times more likely to receive anxiolytic (anti-anxiety) prescriptions. The study also found they were six times more likely to have mood or anxiety disorder healthcare visits and more than six times more likely to be hospitalised following suicide attempts.

1. Bränström, R., & Pachankis, J. E. (2020). “Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: A total population study”: Correction. The American Journal of Psychiatry, 177(8), 734. https://doi.org/10.1176/appi.ajp.2019.19010080 ↩︎